Godel T, Bäumer P, Farschtschi S, Gugel I, Kronlage M,
Hofstadler B, Heiland S, Gelderblom M, Bendszus M, Mautner VF. Peripheral nervous
system alterations in infant and adult neurofibromatosis type 2. Neurology. 2019
Aug 6;93(6):e590-e598.
Abstract
OBJECTIVE:
To examine the involvement of dorsal root ganglia and
peripheral nerves in children with neurofibromatosis type 2 compared to healthy
controls and symptomatic adults by in vivo high-resolution magnetic resonance neurography.
METHODS:
In this prospective multicenter study, the lumbosacral
dorsal root ganglia and sciatic, tibial, and peroneal nerves were examined in 9
polyneuropathy-negative children diagnosed with neurofibromatosis type 2 by a
standardized magnetic resonance neurography protocol at 3T. Volumes of dorsal
root ganglia L3 to S2 and peripheral nerve lesions were assessed and compared
to those of 29 healthy children. Moreover, dorsal root ganglia volumes and
peripheral nerve lesions were compared to those of 14 adults with
neurofibromatosis type 2.
RESULTS:
Compared to healthy controls, dorsal root ganglia
hypertrophy was a consistent finding in children with neurofibromatosis type 2
(L3 +255%, L4 +289%, L5 +250%, S1 +257%, and S2 +218%, p < 0.001) with an
excellent diagnostic accuracy. Moreover, peripheral nerve lesions occurred with
a high frequency in those children compared to healthy controls (18.89 ± 11.11
vs 0.90 ± 1.08, p < 0.001). Children and adults with neurofibromatosis type
2 showed nonsignificant differences in relative dorsal root ganglia hypertrophy
rates (p = 0.85) and peripheral nerve lesions (p = 0.28).
CONCLUSIONS:
Alterations of peripheral nerve segments occur early in the
course of neurofibromatosis type 2 and are evident even in children not
clinically affected by peripheral polyneuropathy. While those early alterations
show similar characteristics compared to adults with neurofibromatosis type 2,
the findings of this study suggest that secondary processes might be
responsible for the development and severity of associated polyneuropathy.
Courtesy of a colleague
No comments:
Post a Comment